chrisvoncsefalvay/vaers-outcomes huggingface dataset:
LOSS OF APPETITE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included non alcohol user, and cigarette smoker (half pack of cigarettes a day), and other pre-existing medical conditions included no medical history. The patient had no known allergies and had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 12-MAY-2021 14:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 13-MAY-2021, the subject experienced loss of appetite. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from loss of appetite. This report was non-serious.
Chills, nausea, possibly passed out, red and hot to the touch rash on chest and back
Patient was given a pfizer bivalent dose as a primary series dose.  Pt parents called and informed with vaccine error and CDC recommendations.
This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 100 F), FATIGUE (body is aching and fatigued), HEADACHE (headache like migraine), ARTHRALGIA (joint pain) and CHILLS (chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in August 2020. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PYREXIA (fever of 100 F), FATIGUE (body is aching and fatigued), HEADACHE (headache like migraine), ARTHRALGIA (joint pain), CHILLS (chills) and PAIN (body is aching and fatigued). At the time of the report, PYREXIA (fever of 100 F), FATIGUE (body is aching and fatigued), HEADACHE (headache like migraine), ARTHRALGIA (joint pain), CHILLS (chills) and PAIN (body is aching and fatigued) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2121, Body temperature: 100 (High) 100 F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. The patient had Covid in August, and she was experiencing every side effects except vomiting after receiving the first dose of mRNA-1273 (Moderna COVID-19 Vaccine). Treatment information was not reported. Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow-up received included no new information.
This spontaneous report received from a registered nurse referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 21-SEP-2016, the patient was vaccinated with VARIVAX (lot: K018961, Expiry date: 15-OCT-2016, dose, frequency, route were not reported) which was improperly stored. No adverse effects reported. The temperature excursions were reported as 44 Fahrenheit (F) for 1 hour, -14.8 Celsius (C) for 1 minute, 8.36 F for 1 hour and -14.23 C for 1 hour. There were no previous excursions reported. Additional information was requested.
Narrative:  Admission Date: Nov 19,2021 Discharge Date: Nov 21,2021 Condition of patient at discharge: Stable Disposition of Patient at Discharge: Home Primary Diagnosis during Admission/Treatment: COVID PNA Secondary Diagnosis(es)during Admission/Treatment: 85 yo male PMH HTN, HPL, CAD s/p multi-vessel, CABG in 2010, aortic bioprosthetic valve replacement in 2010, BPI brought to Emergency Department (ED) for malaise and not doing well at home per EMS. Patient himself is unclear why he is here and family was not able to be contacted for collateral information. Per patient, he stated that his wife thinks that he had been getting more confused recently. Unclear how much more confused this was from his baseline. Patient denied having any shortness of breath or having a hard time breathing, however he did note that he was diagnosed with COVID the previous week (test result unavailable). Patient does not usually require oxygen when at home. He also stated that in the last week he had been having some episodes of diarrhea, however he denied any nausea or vomiting. He denied any fevers, chills, or chest pain as well. He noted that he had a rash on his legs that had been there for awhile, however he did not note to have any pain in his legs. When patient arrived to the ED he was unaccompanied by any family and he was unsure why he was specifically in the ED. He was afebrile and hemodynamically stable. Patient was reportedly desatting to the high 80s on R/ A and was placed on 2L NC. CBC and BMP were largely unremarkable although did have an AKI w/ Cr of 2.15 (BL 1.8-1.9). Cardiac workup insignificant as well. VBG obtained showed a decreased O2. Patient also had a ferritin of 2527 and d-dimer mildly elevated to 1.64. COVID test was positive (despite double vaccination with Pfizer COVID vaccine on 2/1/2021 and 2/22/2021. Patient had CXR notable for airspace disease consistent with COVID and possible superimposed Pneumonia. Given concern for superimposed pneumonia patient received azithromycin and cerftriaxone and was given 1L NS bolus. Brief Summary of Hospital Course: #Covid PNA: Patient required 2L in the ED and does not require O2 at home. Currently COVID positive on 11/19/21 with first COVID positive on 11/9/21. CXR in ED w/ superimposed Pneumonia (PNA), though unconvincing radiographically - symptomatically, patient with no elevated white count, no sputum production, afebrile. Procal 0.14. Initially started on ceftriaxone/azithro, discontinued as evidence more for COVID PNA than bacterial. Initially started dexamethasone 6mh daily due to increased O2 requirement, however patient weaned and stable in room air x 24 hours, discontinued dexamethasone at that time. Patient passed walk test (O2 sat above 90-92 with ambulation) and stable for discharge home. #AKI, improved: Cr 2.15 on admission with baseline around 1.8-1.9. Patient endorses not being as hydrated as normal. S/p 1L NS bolus in Ed. Creatinine downtrended to 1.63 without intervention, back to baseline.
Extremely sore shoulder & arm, becoming progressively worse and still not resolved. It's now 10 weeks later, and it's still very difficult to raise that arm; my range of motion is very restricted; I cannot sleep on that side; and the pain wakes me up at night. I have NO prior history of shoulder/arm problems.
No adverse event occured. Administered expired vaccine on 03/03/2023. Vaccine expired on 03/02/2023.
No adverse reactions observed after administration of medication. Patient starting complaining of shortness of breath around 0500 the following morning. SP02 checked in the 80s. Patient expired 01/09/2021;
Patient presented to the ED on 3/16/21 with syncope and was subsequently hospitalized. Patient also presented to the ED on 4/12/21.
Arm felt internally like it was sitting in an ice bath with intermittent numbness and small bumps around body that itch.
Began having a local reaction.  Spread to current size of  6 in by 4 in.  Warm to touch, area swollen.  Has not progressed in size over past two day.  Somewhat sore, very itchy.  No other symptoms except for the local reaction.
Event occurred after 2nd dose. Patient was diagnosed with COVID 19 Remdesivir In-patient
This spontaneous report as received from a medical assistant refers to 4 year old patient of unknown gender. On an unknown date in April 2014, between 12-APR-2014 and 24-APR-2014, the patient was vaccinated with a dose of VARIVAX lot # J012210, expiry 28-SEP-2015 ("VFC" stock), 0.5 ml, once, intramuscular. The medical assistant stated there was a power outage on 12-APR-2014 and the VARIVAX doses from the freezer needed to be transported to unspecified hospital for proper storage. She stated VARIVAX was exposed to 46F for 1 hour, at worst. There were no prior excursions. There was a site visit from local health department on an unspecified date. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient has been experiencing severe muscle and joint pain from his ankles to his shoulders since three days after his vaccination. Patient's worse pain is in his legs, arms, and shoulders. Physicians have not been able to come up with a diagnosis. Patient has been taking Ibuprofen 800mg TID. Where the vaccine was given pt. had a large red/irritated area.
WELL LINEATED RASH OBSERVED ON PATIENT'S WAIST. PATIENT STATED RASH WENT DOWN BOTH LEGS AND ON BUTTOCKS. C/O ITCHING. NO DRAINAGE NOTED. PATIENT C/O NIGHT SWEATS. STATES SIGNS AND SYMPTOMS STARTED 3 DAYS AFTER VACCINATION. PATIENT STATED HE HAS NOT BEEN TO A PHYSICIAN.
I was on a cruise, and I ended up testing positive for COVID-19 on 6/10/2022. I started having a headache, fever, fatigue, and I didn't want to get out of bed. I called the doctor, on the ship and they came to my room and gave me a COVID-19 test. I couldn't eat for a few days. I was quarantined on the ship, then, when we got off, I was shipped to another state. After that I was able to fly home. I was given medication, but I am unable to find my records that has the medication name in it.
Confusion, Headache, RespDepression, Tachycardia, abdominal pain, slight memory problems, SP02 91-93 X1 week, HR of 150+ at times, racing heart, problems with movement, continued  symptoms for months Narrative:  MD visits and 2 ER visits in April and June for ongoing problems; condition was still ongoing in June 2021 and unsure if it has  resolved now
Pt. states that after receiving the 1st dose of Influenza (Blok) 11/23/2021, started experiencing symptoms of itchiness throughout the facial area and neck area with swelling of the throat (was able to breath sufficiently). Self-treated with Benadryl and Ice Pack applied. Symptoms lasting 36hrs. Primary communications recommendation of Emergency Room visit (N/A). No noted Primary/Emergency Room visit.
Blood pressure was 196\85/Blood Pressure was up next day; Pain in arm, then next day down into right lung area; Pain in arm, then next day down into right lung area; Pleurisy in lung; Hurt to talk, walk, breathe or even move; Hurt to talk, walk, breathe or even move; Hurt to talk, walk, breathe or even move; Hurt to talk, walk, breathe or even move; Lost voice completely; Inflammatory reaction; Weakness this bad; This is a spontaneous report from a contactable consumer (patient). A 71-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiry dates were unknown), via an unspecified route of administration in right arm on 22Feb2021 at 11:15 (at the age of 71-year-old) as unknown dose, single, for COVID-19 immunization, at Clinic. The patient's medical history included asthma, hypertension, penicillin allergy and silver drug allergy; stop date and start dates for all were unknown and unknown if ongoing. Concomitant medications included unspecified medications (within 2 weeks of vaccination). Patient experienced pain in arm, then next day down into right lung area. Went to doctor then to ER, ER did, X-Ray said had pleurisy in lung. Patient's blood pressure was 196\85. Awful pain in right lung. Hurt to talk, walk, breathe or even move, Lost voice completely, had Inflammatory reaction and Weakness this bad: all events were occurred on 23Feb2021 at 09:00 AM. Blood Pressure was up next day after vaccine 154/86. Patient took pain pills, steroids antibiotics and inflammatory medications. Lasted for over 3 weeks. Just now finally getting better. Patient went to primary care doctor, ER. Cardiologist and Going to lung doctor this Wednesday. Patient still have some pain in right lung area. Cardiologist said it sounded like an inflammatory reaction to the shot. Patient do have asthma so didn't, think much at first but never have this much pain. Nor high blood pressure. I laid on couch or bed for days after the shot. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was diagnosed with COVID-19, Prior to vaccination. The patient was tested for COVID-19 and resulted as negative on 19Mar2021. Patient administered into ER and went to physician office visit for all the events. Seriousness of the events was reported as non-serious. Patient received the treatment for all the events. Outcome of the events was recovering.   Information about lot/batch number is requested.
This spontaneous report was received from a physician, via company representatives, and refers to a patient of unknown age and gender. Information about the patient's pertinent medical history, drug reactions or allergies and concomitant medication was not reported. On 25-JUN-2015, the patient was vaccinated with an improperly stored dose of VAQTA 10 Pk 25 U/0.5 ml SD Llok w Cap Ped, which had the lot # L001445, with expiration date 15-FEB-2016 (dose, dosage number and route of administration were not reported). No adverse effects were reported and no product quality complaint was involved. On an unspecified date the vaccine experienced a temperature excursions of 24 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius degree). The vaccine status was reports as "in excursion". The vaccine storage criteria and the storage type were reported as "Refrigerator(R)". This is one of the several reports received from the same reporter. Additional information has been requested.
Urticaria (about 1cm x 2 cm), pruritis, erythema
Second dose of Jynneos was administered on day 18 instead on day 28; Case reference number US-BN-2022-002182 is a spontaneous case report initially received on 31-Aug-2022 from other health care professional (reference number: USBAV22-1237) and concerns a male patient.  The patient's relevant medical history and concomitant medications were not reported.  On 12-Aug-2022, the patient was vaccinated with first dose of Jynneos vaccine (Smallpox and Monkeypox Vaccine, Live, Nonreplicating; batch number: FDP00016) at dose of 0.5 ml, at an unknown route or anatomical site for monkeypox prophylaxis.  On 30-Aug-2022, 18 days after the first dose, the patient was vaccinated with second dose of Jynneos vaccine (Smallpox and Monkeypox Vaccine, Live, Nonreplicating; batch number: FDP00016) at dose of 0.5 ml, at an unknown route or anatomical site for monkeypox prophylaxis (explicitly coded as 'Inappropriate schedule of vaccine administered').  At the time of this report, it was unknown if the patient experienced adverse event.  Additional information received on 31-Aug-2022 from Bavarian Nordic included local number.  The case is linked with US-BN-2022-002180, US-BN-2022-002181, US-BN-2022-002182, US-BN-2022-002183 due to the same reporter.; Reporter's Comments: A male patient, was vaccinated with the second dose of Jynneos (18 days after the first dose), at dose of 0.5 ml, at an unknown route or anatomical site for monkeypox prophylaxis which is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company. At this point, it was unknown if the patient experienced adverse event. The patient's relevant medical history and concomitant medications were not reported. Causal relationship is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A male patient born in 1956, was vaccinated with the second dose of Jynneos (18 days after the first dose), at dose of 0.5 ml, at an unknown route or anatomical site for monkeypox prophylaxis which is considered as inappropriate schedule of vaccine administered. Inappropriate schedule of product administration is considered listed per company. At this point, it was unknown if the patient experienced adverse event. The patient's relevant medical history and concomitant medications were not reported. Causal relationship is assessed as not related to suspect product but to human factor. The case is non-serious.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On 14-JAN-2014 the patient was vaccinated with ZOSTAVAX (lot # J011333, expiry date 13-DEC-2014) 0.65 ml, subcutaneously (dosing regimen and frequency unknown) for vaccination. Other suspect therapies included diphtheria toxoid (+) pertussis whole cell vaccine (+) tetanus toxoid (manufacture unknown) (lot number and expiry date unknown) (dosing regimen and frequency unknown) administered on a different arm than the ZOSTAVAX on 14-JAN-2014. On 16-JAN-2014, the patient experienced a 2 inch rash had developed at the injection site the rash is not bumpy but it is sore. It was reported that the patient sought medical attention and came to see the pharmacist. The outcome of the event was unknown. The action taken with the therapy with ZOSTAVAX and vaccine (+) tetanus toxoid (manufacturer unknown) was unknown. The relatedness of the events to the therapy with ZOSTAVAX and vaccine (+) tetanus toxoid (manufacture unknown) was unknown. Additional information has been requested.
Injection site red, swollen, and warm. Patient instructed to apply ice, take OTC NSAIDS, & follow up with MD. Notified Rph on day 3.
Office visit at clinic following vaccination on 11/10/2006. Right upper arm cellulitis red/inflammed secondary to Pneumovax vaccine. Swelling, pain. Augmentin 500mg BID for 10 days.
Felt fine day of shot. Next day low fever 100.6 chills, tired , generalized aches rap hand joints. Now arm soreness atvi jection site and a red small rash distal to site
This spontaneous report as received from registered nurse refers to unspecified number of patients. No information regarding current condition, medical history or drug allergies were reported. On an unknown date the unspecified number of patients were vaccinated with improperly stored LIQUID PEDVAXHIB (strength, dose unit, lot number and frequency unknown) for routine vaccination. No concomitant therapy was reported. No adverse effect was reported. The outcome of event was unknown. No further adverse event information was provided. This is one of several reports received from the same source. Additional information has been requested.
Child with fever to 102, varicella like rash on arms and legs consistant with chicken pox.
The patient received the PREVNAR 13 vaccination on 6/20/16. He called the clinic on 6/28/16 to inquire about another health issue, but also reported at that time that since the vaccination, he had experienced high fever, chills, and body/joint aches for 4 days, but that he was currently feeling better at that time. Arthralgia and fever.
This spontaneous report was received from a health care professional refers to a patient of unknown age and gender. On 06-MAY-2015 the patient was vaccinated with improperly stored (Oka/Merck) VARIVAX injection (lot # K018961; expiry: 15-OCT-2016) (dose, route and frequency unspecified). No concomitant medications were reported. No adverse effects reported. There was no product quality complaint involved. The outcome of incorrect product storage was unknown. No further information provided. This is one of several reports received from the same source. Additional information has been requested.
Pink swollen area on my left Upper arm; Vaccination site warmth; It would be itchy; Red area around the injection site about 4x4; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Pink swollen area on my left Upper arm), VACCINATION SITE WARMTH (Vaccination site warmth), PRURITUS (It would be itchy) and VACCINATION SITE ERYTHEMA (Red area around the injection site about 4x4) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high since 1987. Concomitant products included HCTZ and LOSARTAN POTASSIUM (LOSATAN) for Blood pressure high, CALCIUM CITRATE, COLECALCIFEROL (CITRACAL + D [CALCIUM CITRATE;COLECALCIFEROL]) for Bone loss, POTASSIUM for Potassium deficiency, PRAVASTATIN SODIUM, CARVEDILOL, IRON, AMLODIPINE and CENTRUM SILVER [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM;CHROMIUM;COLECALCIFEROL;COPPER;FOLIC ACID;IODINE;IRON;LYCOPENE;MAGNESIUM;MANGANESE;NICOTINAMIDE;PANTOTHENIC ACID;PHOSPHORUS;PHYTOMENADIONE;POTASSIUM;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PERIPHERAL SWELLING (Pink swollen area on my left Upper arm), VACCINATION SITE WARMTH (Vaccination site warmth) and VACCINATION SITE ERYTHEMA (Red area around the injection site about 4x4). On an unknown date, the patient experienced PRURITUS (It would be itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Pink swollen area on my left Upper arm), VACCINATION SITE WARMTH (Vaccination site warmth), PRURITUS (It would be itchy) and VACCINATION SITE ERYTHEMA (Red area around the injection site about 4x4) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: NNI On 06-May-2021: Patient demographics were added. New events pink swollen area on left upper arm, itchy were added.  Concomitant product information was added. On 15-Jun-2021: MSA notes were added.
Chills, fever, fatigue,  nausea, vomiting,  headache, started the next day, persisted for 2 days, gradually improving , no treatment aside from tylenol
30SEP97 pt recv vax & 1OCT97 devel fever 3PM w/flu like sx;4OCT97 fever inc 102-105-seen by MD rx APAP/advil;3OCT97 mom report to hlth dept;
28 y/O male immediately post-vaccined reported feeling faint and lightheaded. The patient was  assisted to a wheelchair and  taken for observation. He reports no known h/o vasovagal symptoms. He did however admitted he had not eaten. He was placed in Trendelenburg position for recovery and later sat up after being offered crackers and a drink. Vitals 151/76 HR, 65 O2 sat 98%.  The patient was unable to complete the snack and started to experience chills, fatigue, chest pressure with palpitation and numbness and tingling down his left arm. EMS was called. The patient was observed for additional time, the chills resolved but but the chest pressure and lightheadedness persisted,
CHEST PAIN, CONSTANT HEADACHE, TROUBLE BREATHING, CHEST TIGHTNESS, ASTHMA WORSENED.
The pt reports left arm swelling, redness with streaks after receiving vaccination. The pt went to the ER for treatment on 1/20/01. the pt was treated with antibiotics.